From Biology to Therapy: The CLL Success Story

Chemoimmunotherapy has been the standard of care for patients with chronic lymphocytic leukemia (CLL) over the last decade. Advances in monoclonal antibody technology have resulted in the development of newer generations of anti-CD20 antibodies with improved therapeutic effectiveness. In parallel, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yosifov, Deyan Y., Wolf, Christine, Stilgenbauer, Stephan, Mertens, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746030/
https://www.ncbi.nlm.nih.gov/pubmed/31723816
http://dx.doi.org/10.1097/HS9.0000000000000175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746030/
https://www.ncbi.nlm.nih.gov/pubmed/31723816
http://dx.doi.org/10.1097/HS9.0000000000000175

Ejemplares similares